Aurobindo Pharma to attend investor dialogue in Mumbai

Aurobindo Pharma Limited announced its participation in an investor meeting, the Ashwamedh – Elara India Dialogue 2025, scheduled for September 4, 2025. Company officials will engage in in-person and group meetings from 9:00 AM to 6:00 PM (IST) in Mumbai. This engagement is intended to facilitate discussions with the investment community.

The schedule of the meeting remains subject to change, potentially due to exigencies on the part of either the investor or the company. Aurobindo Pharma Limited explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions. The announcement, dated August 29, 2025, was formally communicated to the National Stock Exchange of India Limited and BSE Limited.

B. Adi Reddy, company secretary, digitally signed the intimation, confirming the company's commitment to transparent communication with its stakeholders and adherence to regulatory compliance.